03.01.09
Denmark-based Chr. Hansen has acquired Urex Biotech Inc. in an effort to expand its development of probiotics for dietary supplements, while also entering a North American distribution agreement with Cyvex Nutrition. Chr. Hansen and Urex Biotech Inc. entered a strategic alliance in 2004 to develop and promote therapeutic solutions for women’s health issues based on proven probiotic strains. Urex is an oral probiotic concept that restores and maintains a healthy vaginal flora, which may reduce the risk of infections. Chr. Hansen North America has also entered an agreement with Cyvex Nutrition, which will become the exclusive distributor in the dietary supplement channel for its line of phytonutrients.